Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 5
1961 3
1962 3
1963 5
1964 4
1965 5
1966 6
1967 1
1968 1
1972 3
1973 1
1974 2
1975 2
1976 2
1977 1
1978 1
1979 2
1999 1
2009 4
2013 1
2020 1
2021 1
2022 3
2023 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Assessment of Baseline Ultrawidefield Fluorescein Angiographic Quantitative Leakage Parameters with Ultrawidefield Fundus Features and Clinical Parameters in Diabetic Retinopathy in Protocol AA.
Writing Committee for the DRCR Retina Network; Ehlers JP, Josic K, Yordi S, Martin A, Srivastava SK, Sun JK. Writing Committee for the DRCR Retina Network, et al. Ophthalmol Retina. 2025 Mar;9(3):243-252. doi: 10.1016/j.oret.2024.08.015. Epub 2024 Aug 30. Ophthalmol Retina. 2025. PMID: 39216727
Conception Control.
Ringrose CA. Ringrose CA. Can Med Assoc J. 1963 Dec 7;89(23):1199. Can Med Assoc J. 1963. PMID: 20327726 Free PMC article. No abstract available.
INTRAVENOUS COMPLICATIONS.
RINGROSE CA. RINGROSE CA. Appl Ther. 1964 Dec;6:1004-7. Appl Ther. 1964. PMID: 14236625 No abstract available.
THE CONTROVERSIAL AND DYNAMIC OVARY.
RINGROSE CA. RINGROSE CA. Can Med Assoc J. 1963 Sep 28;89(13):641-5. Can Med Assoc J. 1963. PMID: 14077809 Free PMC article.
Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement.
Blagden SP, Billingham L, Brown LC, Buckland SW, Cooper AM, Ellis S, Fisher W, Hughes H, Keatley DA, Maignen FM, Morozov A, Navaie W, Pearson S, Shaaban A, Wydenbach K, Kearns PR; Experimental Cancer Medicine Centres (ECMC) CID trials working group. Blagden SP, et al. Br J Cancer. 2020 Feb;122(4):473-482. doi: 10.1038/s41416-019-0653-9. Epub 2020 Jan 6. Br J Cancer. 2020. PMID: 31907370 Free PMC article. Review.
Office tubal sterilization.
Ringrose CA. Ringrose CA. Obstet Gynecol. 1973 Jul;42(1):151-5. Obstet Gynecol. 1973. PMID: 4720201 No abstract available.
Maternal Mortality Studies.
Ringrose CA. Ringrose CA. Can Med Assoc J. 1965 Oct 16;93(16):885. Can Med Assoc J. 1965. PMID: 20328388 Free PMC article. No abstract available.
Letter: Therapeutic abortion.
Ringrose CA. Ringrose CA. Can Med Assoc J. 1975 Jan 11;112(1):22, 25. Can Med Assoc J. 1975. PMID: 1109716 Free PMC article. No abstract available.
62 results